Dimitra-Ifigeneia Matara, MD, PhD

Dr. Dimitra-Ifigeneia Matara, MD, PhD

National and Kapodistrian University of Athens School of Health Sciences, Department of Medicine, Athens, Greece
orcid
Paediatrician, Academic Scholar/Scientific Collaborator, 2nd...

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Dimitra-Ifigeneia Matara, MD, PhDDimitra-Ifigeneia Matara, MD, PhD
Dimitra-Ifigeneia Matara, MD, PhD
APAbraham Pouliakis
Abraham Pouliakis
Theodoros XanthosTheodoros Xanthos
Theodoros Xanthos
Rozeta SokouRozeta Sokou
Rozeta Sokou
GKGeorgios Kafalidis
Georgios Kafalidis
CSChristos Salakos
Christos Salakos
The microbiome is vital for the proper function of the gastrointestinal tract (GIT) and the maintenance of overall wellbeing. Gut ischemia may lead to disruption of the intestinal mucosal barrier, resulting in bacterial translocation. In this systematic review, according to PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) guidelines, we constructed a search query using the PICOT (Patient, Intervention, Comparison, Outcome, Time) framework. Eligible studies reported in PubMed, up to April 2021 were selected, from which, 57 publications’ data were included. According to these, escape of intraluminal potentially harmful factors into the systemic circulation and their transmission to distant organs and tissues, in utero, at birth, or immediately after, can be caused by reduced blood oxygenation. Various factors are involved in this situation. The GIT is a target organ, with high sensitivity to ischemia–hypoxia, and even short periods of ischemia may cause significant local tissue damage. Fetal hypoxia and perinatal asphyxia reduce bowel motility, especially in preterm neonates. Despite the fact that microbiome arouse the interest of scientists in recent decades, the pathophysiologic patterns which mediate in perinatal hypoxia/asphyxia conditions and gut function have not yet been well understood.

28 September 2025 in Cells
Verified
Journal Article
Open access
PDF file
Filippos FilippatosFilippos Filippatos
Filippos Filippatos
Dimitra-Ifigeneia Matara, MD, PhDDimitra-Ifigeneia Matara, MD, PhD
Dimitra-Ifigeneia Matara, MD, PhD
Athanasios MichosAthanasios Michos
Athanasios Michos
KKKonstantinos Kakleas
Konstantinos Kakleas
As the pediatric COVID-19 landscape evolves, it is essential to evaluate whether SARS-CoV-2 infection predisposes children to allergic disorders. This narrative review synthesizes current epidemiological and immunological evidence linking pediatric COVID-19 with new-onset atopy. Epidemiological data remain heterogeneous: large Korean and multinational cohorts report increased risks of asthma and allergic rhinitis following COVID-19, whereas U.S. cohorts show neutral or protective associations, highlighting geographic and methodological variability. Mechanistic insights provide biological plausibility: epithelial injury and the release of alarmin cytokines (IL-33, IL-25, TSLP) promote Th2 polarization and ILC2 expansion, while epigenetic “scars” (e.g., LMAN2 methylation changes) and hematopoietic stem cell reprogramming may sustain long-term Th2 bias. Cytokine memory involving IL-7 and IL-15 contributes to altered T- and B-cell homeostasis, whereas disrupted regulatory T-cell function may reduce tolerance thresholds. Paradoxical trade-offs exist, such as ACE2 downregulation in allergic airways, which may lower viral entry but simultaneously amplify type-2 inflammation. Together, these processes suggest that SARS-CoV-2 infection could foster a pro-allergic milieu in susceptible children. Although current evidence is inconclusive, integrating epidemiological surveillance with mechanistic studies is crucial for predicting and alleviating post-COVID allergic outcomes. Longitudinal pediatric cohorts and interventions targeting epithelial alarmins or microbiome restoration may hold promise for prevention.

9 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Dimitra-Ifigeneia Matara, MD, PhDDimitra-Ifigeneia Matara, MD, PhD
Dimitra-Ifigeneia Matara, MD, PhD
Rozeta SokouRozeta Sokou
Rozeta Sokou
Theodoros XanthosTheodoros Xanthos
Theodoros Xanthos
APAbraham Pouliakis
Abraham Pouliakis
Antigoni SarantakiAntigoni Sarantaki
Antigoni Sarantaki
NICOLETTA IACOVIDOUNICOLETTA IACOVIDOU
NICOLETTA IACOVIDOU
Background: The term “bacterial translocation” (BT) refers to the migration of bacteria or their products from the gastrointestinal tract to tissues located outside it, and may occur after intestinal ischemia-reperfusion injury. The term “endotoxin” is synonymous, and is used interchangeably with the term lipopolysaccharide (LPS). LPS, a component of Gram-negative gut bacteria, is a potent microbial virulence factor, that can trigger production of pro-inflammatory mediators, causing localized and systemic inflammation. The aim of this study is to investigate if neonatal asphyxia provokes BT and an increased concentration of LPS in an animal model of asphyxia in piglets. Methods: Twenty-one (21) newborn male Landrace/Large White piglets, 1–4 days old, were randomly allocated into three groups, Control (A), Asphyxia (B) and Asphyxia-Cardiopulmonary Resuscitation (CPR) (C). All animals were instrumented, anesthetized and underwent hemodynamic monitoring. In Group A, the animals were euthanized. In Group B, the endotracheal tube was occluded to cause asphyxia leading to cardiopulmonary arrest. In Group C, the animals were resuscitated after asphyxia and further monitored for 30′. Bacterial translocation was assessed by the measurement of endotoxin in blood from the portal vein and the aorta, and also by the measurement of endotoxin in mesenteric lymph nodes (MLNs) at euthanasia. The results are given as median (IQR) with LPS concentration in EU/mL. Results: BT was observed in all groups with minimum LPS concentration in the MLN and maximum concentration in the portal vein. LPS levels in the MLNs were higher in the Group B: 6.38 EU/mL (2.69–9.34) compared to the other groups (Group A: 2.1 EU/mL (1.08–2.52), Group C: 1.66 EU/mL (1.51–2.48), p = 0.012). The aorta to MLNs LPS difference (%) was lower in Group B: 0.13% (0.04–1.17), compared to Group A: 5.08% (2.2–10.7), and Group C: 3.42% (1.5–5.1)) (p = 0.042). The same was detected for portal to MLNs LPS difference (%) which was lower in Group B: 0.94% (0.5–3) compared to Group A: 4.9% (4–15), and Group C: 3.85% (1.5–5.1)) (p = 0.044). Conclusions: Neonatal asphyxia can provoke ΒΤ and increased LPS concentration in blood and tissue located outside the gastrointestinal system.

23 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Filippos FilippatosFilippos Filippatos
Filippos Filippatos
VKVasiliki Maria Kymioni
Vasiliki Maria Kymioni
DKDimitra Kallitsounaki
Dimitra Kallitsounaki
Spyridon KarageorgosSpyridon Karageorgos
Spyridon Karageorgos
Dimitra-Ifigeneia Matara, MD, PhDDimitra-Ifigeneia Matara, MD, PhD
Dimitra-Ifigeneia Matara, MD, PhD
KKKonstantinos Kakleas
Konstantinos Kakleas
Background: Pediatric transfers to tertiary hospitals may reflect disparities in regional healthcare capacity and impose substantial healthcare costs. However, data regarding pediatric transfer pathways, tertiary-care utilization, and transport-related expenditure in Greece remain limited. Methods: We conducted a retrospective observational study of children aged 0–16 years transferred to a tertiary children's hospital in Athens, Greece, during 2022–2023. Transfers were classified as prehospital emergency medical service (EMS) transports or interfacility transfers. Post-transfer outcomes were analysed using a predefined binary endpoint: ED/short-stay discharge versus tertiary hospital-level care/admission. Potentially avoidable transfers were identified using conservative predefined resource-utilization criteria. Transport costs were analysed descriptively according to transport modality and geographic region. Results: A total of 423 pediatric transfers were analysed, including 216/423 (51.1%) prehospital EMS transports and 207/423 (48.9%) interfacility transfers. Overall, 224/423 children (53.0%) required tertiary hospital-level care/admission, whereas 199/423 (47.0%) were managed as ED/short-stay discharges. Importantly, only 54/199 ED/short-stay discharge cases met the stricter criteria for potential avoidability, representing 54/423 (12.8%) of all transfers. Ground ambulance accounted for most transfers, whereas air and sea transport accounted for only 12.1% of transfers, but 97.0% of transport-related expenditure. Interfacility transfers were substantially more likely than prehospital EMS transports to require tertiary hospital-level care/admission (OR 3.72, 95% CI 2.49–5.57; p < 0.001) and accounted for 93.8% of total transport costs. Conclusions: Most pediatric transfers were associated with clinically meaningful tertiary-level care, and only a minority met predefined criteria for potential avoidability. Interfacility transfers demonstrated substantially higher tertiary-care utilization and disproportionately concentrated transport expenditure, highlighting the importance of strengthening regional pediatric capacity and optimizing referral networks to improve the efficiency of pediatric transfer systems.

31 August 2026 in Children
Verified
Journal Article
Open access
PDF file
Filippos FilippatosFilippos Filippatos
Filippos Filippatos
VKVasiliki Maria Kymioni
Vasiliki Maria Kymioni
DKDimitra Kallitsounaki
Dimitra Kallitsounaki
SKSpyridon Karageorgos
Spyridon Karageorgos
Dimitra-Ifigeneia Matara, MD, PhDDimitra-Ifigeneia Matara, MD, PhD
Dimitra-Ifigeneia Matara, MD, PhD
KKKonstantinos Kakleas
Konstantinos Kakleas
Background: Pediatric transfers to tertiary hospitals may vary according to geographic origin and referral pathways and may impose substantial healthcare costs. However, data regarding pediatric transfer pathways, tertiary hospital-level care/admission, and transport-related expenditure in Greece remain limited. Methods: We conducted a retrospective observational study of children aged 0–16 years transferred to a tertiary children’s hospital in Athens, Greece, during 2022–2023. Transfers were classified as prehospital emergency medical service (EMS) transports or interfacility transfers. Post-transfer outcomes were analysed using a predefined binary endpoint: ED/short-stay discharge versus tertiary hospital-level care/admission. Potentially avoidable transfers were identified using conservative predefined resource-utilization criteria. Transport costs were analysed descriptively according to transport modality and geographic region. Results: A total of 423 pediatric transfers were analysed, including 216/423 (51.1%) prehospital EMS transports and 207/423 (48.9%) interfacility transfers. Overall, 224/423 children (53.0%) required tertiary hospital-level care/admission, whereas 199/423 (47.0%) were managed as ED/short-stay discharges. Importantly, only 54/199 ED/short-stay discharge cases met the stricter criteria for potential avoidability, representing 54/423 (12.8%) of all transfers. Ground ambulance accounted for most transfers, whereas air and sea transport accounted for only 12.1% of transfers, but 97.0% of transport-related expenditure. In unadjusted pathway-level analysis, interfacility transfer was associated with higher odds of tertiary hospital-level care/admission than prehospital EMS transport (OR 3.72, 95% CI 2.49–5.57; p < 0.001) and accounted for 93.8% of total transport costs. Conclusions: Most pediatric transfers resulted in tertiary hospital-level care/admission, and only a minority met the predefined criteria for potential avoidability. A substantially higher proportion of interfacility transfers resulted in tertiary hospital-level care/admission, and these transfers accounted for a disproportionate share of recorded transport expenditure.